BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31631520)

  • 1. Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Rajkumar CA; Cook C; Shalhoub J; Chukwuemeka A; Jaffer U; Hadjiloizou N; Sen S; Ruparelia N; Mikhail G; Malik IS
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):E747-E754. PubMed ID: 31631520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease.
    Hysi I; Gommeaux A; Pécheux M; Hochart P; Hannebicque G; Pâris M; Manchuelle A; Fabre O
    Semin Thorac Cardiovasc Surg; 2019; 31(2):175-180. PubMed ID: 30291887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcarotid Approach for Transcatheter Aortic Valve Replacement With the Sapien 3 Prosthesis: A Multicenter French Registry.
    Overtchouk P; Folliguet T; Pinaud F; Fouquet O; Pernot M; Bonnet G; Hubert M; Lapeze J; Claudel JP; Ghostine S; Azmoun A; Caussin C; Zannis K; Harmouche M; Verhoye JP; Lafont A; Chamandi C; Ruggieri VG; Di Cesare A; Leclercq F; Gandet T; Modine T
    JACC Cardiovasc Interv; 2019 Mar; 12(5):413-419. PubMed ID: 30772290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Sinha S; Khan A; Qureshi AM; Suh W; Laks H; Aboulhosn J; Biniwale R; Adachi I; Fernando A; Levi D
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):253-261. PubMed ID: 31609055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report.
    Dahle TG; Kaneko T; McCabe JM
    JACC Cardiovasc Interv; 2019 Apr; 12(7):662-669. PubMed ID: 30947940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Access After TAVR.
    Ochiai T; Chakravarty T; Yoon SH; Kaewkes D; Flint N; Patel V; Mahani S; Tiwana R; Sekhon N; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Mar; 13(6):693-705. PubMed ID: 32192689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAPIEN 3 Ultra - Design and procedural features of a new balloon-expandable valve.
    Parma R; Hudziak D; Smolka G; Gocoł R; Ochała A; Wojakowski W
    Cardiol J; 2020; 27(2):194-196. PubMed ID: 31565790
    [No Abstract]   [Full Text] [Related]  

  • 12. Completely Percutaneous Transaxillary Aortic Valve Implantation Under Local Anesthesia: A Minimalist Alternative Access Approach.
    Ooms JF; Van Mieghem NM
    JACC Cardiovasc Interv; 2019 Jan; 12(1):e1-e2. PubMed ID: 30553709
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Abdelghani M; Allali A; Kaur J; Hemetsberger R; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):971-979. PubMed ID: 30467966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture of the delivery balloon shaft during balloon-expandable prosthesis alignment during implantation of an Edwards SAPIEN 3.
    Arai T; Hovasse T; Chevalier B
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):997-999. PubMed ID: 27142180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinhole Balloon Rupture During Valve Alignment in TAVR Using SAPIEN 3.
    Kadoya Y; Zen K; Kuwabara K; Ito N; Yamano T; Nakamura T; Matoba S
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1188-1189. PubMed ID: 31153839
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel adaptations in percutaneous right transaxillary access for transcatheter aortic valve implantation using the sapien ultra valve.
    Waleed M; Arunothayaraj S; McGrath S; Michail M; Cockburn J; Hildick-Smith D
    J Invasive Cardiol; 2023 Jul; 35(7):E355-E364. PubMed ID: 37769621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.
    Mauri V; Reimann A; Stern D; Scherner M; Kuhn E; Rudolph V; Rosenkranz S; Eghbalzadeh K; Friedrichs K; Wahlers T; Baldus S; Madershahian N; Rudolph TK
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2200-2209. PubMed ID: 27832845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
    JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.